GlaxoSmithKline ($GSK) may have sequestered its HIV drugs and development in a joint venture with Pfizer ($PFE), ViiV Healthcare. But that doesn't mean the U.K.-based drugmaker intends to spin off the…
TOKYO, Oct 29 (Reuters) - Japan's Shionogi & Co said on Monday that it will take a 10 percent stake in Viiv Healthcare, a AIDS drug joint venture between GlaxoSmithKline and Pfizer, in exchange…
ViiV/Shionogi's dolutegravir beats Gilead drug in HIV study…
